CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 300 enrolled
Drug / intervention
HIV testother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06282328
NCT06282328N/ACompleted

HIV HOspital TEsting: Bringing the Hidden to Light in the Hospital Setting: A Monocentric Observational Cross-Sectional Study

Castagna Antonella·observational·Posted Feb 28, 2024·Updated Mar 30, 2026

In Brief

An observational study evaluating HIV test for Hiv and 2 related conditions. Completed, enrolled 300 participants across 1 site.

Detailed Summary

This study aims to evaluate the prevalence of previously undiagnosed HIV infection in the hospital setting (across various medical or surgical departments) among individuals exhibiting at least one HIV indicator condition (HIV-IC) and/or engaging in risky behaviors. This is a cross-sectional, single-center study with additional procedures. Data collection will involve clinical and laboratory data from individuals with at least one HIV-IC and/or behavioral risk factor for HIV infection admitted to the San Raffaele Hospital in Milan for any reason. The overall study duration is 24 months, with recruitment lasting 20 months. Individuals will be actively recruited from various medical or surgical units of the hospital. After obtaining informed consent, clinical and laboratory information related to the study will be collected, along with specific blood samples. The presence of at least one HIV-IC will be determined using available clinical, radiological, and laboratory parameters during hospitalization. Following informed consent, hospitalized individuals will complete a paper questionnaire, aimed at identifying behavioral risk factors for HIV infection. If at least one HIV-IC or behavioral risk factor is present, the person will be eligible for inclusion in the clinical study, and a rapid capillary HIV test will be conducted bedside. In case of a positive rapid capillary HIV test result, antigen/antibody testing and Western Blot for HIV confirmation will be performed on venous blood samples on the same day.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHiv, HIV Infections, AIDS
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedFeb 28, 2024
Enrollment StartFeb 14, 2024
Primary CompletionOct 15, 2025
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 2.3 years ago

Interventions

HIV testother

Bedside rapid capillary HIV test